Improved Predictability of Hepatic Clearance with Optimal pH for Acyl-Glucuronidation in Liver Microsomes.

Acyl-glucuronide Carboxylic acid Clearance Glucuronidation Intracellular pH Optimal pH buffer pH microsome

Journal

Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R

Informations de publication

Date de publication:
11 2022
Historique:
received: 16 05 2022
revised: 30 07 2022
accepted: 11 08 2022
pubmed: 23 8 2022
medline: 19 10 2022
entrez: 22 8 2022
Statut: ppublish

Résumé

The purpose of this study was to investigate the optimal pH for acyl-glucuronidation formation with carboxylic acid-containing compounds in human and rat liver microsomes to improve the predictability of their hepatic clearance. The optimal pH for acyl-glucuronidation of all 17 compounds was around pH 6.0 in human and rat liver microsomes. Correlation analysis was done with the predicted in vitro intrinsic clearance (CL

Identifiants

pubmed: 35995204
pii: S0022-3549(22)00350-1
doi: 10.1016/j.xphs.2022.08.015
pii:
doi:

Substances chimiques

Carboxylic Acids 0
Glucuronosyltransferase EC 2.4.1.17

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3165-3173

Informations de copyright

Copyright © 2022 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Tohru Mizutare (T)

Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., Osaka, Japan. Electronic address: tooru.mizutare@shionogi.co.jp.

Seigo Sanoh (S)

Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; School of Pharmaceutical Sciences, Wakayama Medical University, Wakayama, Japan. Electronic address: sanoh@wakayama-med.ac.jp.

Takushi Kanazu (T)

Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., Osaka, Japan.

Shigeru Ohta (S)

Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; School of Pharmaceutical Sciences, Wakayama Medical University, Wakayama, Japan.

Yaichiro Kotake (Y)

Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH